Compare Suven Life Sciences with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES TTK HEALTHCARE SUVEN LIFE SCIENCES/
TTK HEALTHCARE
 
P/E (TTM) x -95.5 12.6 - View Chart
P/BV x 1.5 1.8 82.2% View Chart
Dividend Yield % 1.5 0.8 180.9%  

Financials

 SUVEN LIFE SCIENCES   TTK HEALTHCARE
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
TTK HEALTHCARE
Mar-19
SUVEN LIFE SCIENCES/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3381,215 27.8%   
Low Rs169610 27.8%   
Sales per share (Unadj.) Rs52.1444.4 11.7%  
Earnings per share (Unadj.) Rs6.817.2 39.6%  
Cash flow per share (Unadj.) Rs8.627.6 31.0%  
Dividends per share (Unadj.) Rs1.505.00 30.0%  
Dividend yield (eoy) %0.60.5 108.0%  
Book value per share (Unadj.) Rs65.3177.9 36.7%  
Shares outstanding (eoy) m127.2814.13 900.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.1 236.8%   
Avg P/E ratio x37.152.9 70.2%  
P/CF ratio (eoy) x29.633.0 89.6%  
Price / Book Value ratio x3.95.1 75.7%  
Dividend payout %22.029.0 75.7%   
Avg Mkt Cap Rs m32,27212,894 250.3%   
No. of employees `0001.12.3 46.8%   
Total wages/salary Rs m6611,307 50.6%   
Avg. sales/employee Rs Th6,132.22,715.7 225.8%   
Avg. wages/employee Rs Th611.1565.3 108.1%   
Avg. net profit/employee Rs Th803.5105.4 762.3%   
INCOME DATA
Net Sales Rs m6,6356,279 105.7%  
Other income Rs m24278 312.6%   
Total revenues Rs m6,8776,356 108.2%   
Gross profit Rs m1,604496 323.7%  
Depreciation Rs m221147 150.9%   
Interest Rs m3834 111.5%   
Profit before tax Rs m1,587393 404.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718149 482.2%   
Profit after tax Rs m869244 356.8%  
Gross profit margin %24.27.9 306.3%  
Effective tax rate %45.237.9 119.3%   
Net profit margin %13.13.9 337.6%  
BALANCE SHEET DATA
Current assets Rs m6,2322,717 229.4%   
Current liabilities Rs m1,4901,571 94.9%   
Net working cap to sales %71.518.3 391.4%  
Current ratio x4.21.7 241.8%  
Inventory Days Days8632 268.8%  
Debtors Days Days8347 177.1%  
Net fixed assets Rs m4,043991 408.0%   
Share capital Rs m127141 90.1%   
"Free" reserves Rs m8,1832,373 344.8%   
Net worth Rs m8,3102,514 330.5%   
Long term debt Rs m183 523.5%   
Total assets Rs m10,3894,158 249.8%  
Interest coverage x43.112.6 341.7%   
Debt to equity ratio x00 158.4%  
Sales to assets ratio x0.61.5 42.3%   
Return on assets %8.76.7 130.8%  
Return on equity %10.59.7 107.9%  
Return on capital %19.516.9 115.2%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m5,622225 2,496.3%   
Fx outflow Rs m1,79971 2,530.5%   
Net fx Rs m3,822154 2,480.6%   
CASH FLOW
From Operations Rs m356173 205.4%  
From Investments Rs m-27997 -288.7%  
From Financial Activity Rs m-225-307 73.3%  
Net Cashflow Rs m-148-38 393.1%  

Share Holding

Indian Promoters % 63.4 65.4 96.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 0.0 5.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 25.8 141.5%  
Shareholders   37,287 12,723 293.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   ALEMBIC  NEULAND LABS  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SHASUN PHARMA  

Compare SUVEN LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Interglobe Aviation QIP, Rising Premium for Non-Life Insurers, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended lower yesterday. Benchmark indices ended nearly 1% lower, tracking weakness in global markets and dragged primarily by finance and banking stocks.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


May 11, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES - PFIZER COMPARISON

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS